RASP — Actavia Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Actavia Life Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	C2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.05	0.014	0.011	0.039	0.075
Net Total Receivables	0.014	0.001	0	—	—
Prepaid Expenses
Total Current Assets	0.072	0.033	0.045	0.085	0.096
Gross Property, Plant And Equipment
Net Property, Plant And Equipment	0.238	0	0	—	—
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	4.95	0.033	0.045	0.085	0.096
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.41	2.71	2.8	1.68	2.05
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	2.41	2.71	2.8	1.77	2.05
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.54	-2.67	-2.75	-1.69	-1.96
Total Liabilities & Shareholders' Equity	4.95	0.033	0.045	0.085	0.096
Total Common Shares Outstanding